Key result
Frailty linked to ~22-fold higher 12-month MACE risk in elderly chronic coronary syndrome patients.
Why the study?
The study was conducted to define frailty in patients aged ≥ 70 years with chronic coronary syndrome and to evaluate its prognostic significance and impact on mortality.
Does frailty increase the risk of MACE and mortality in elderly patients with chronic coronary syndrome?
Cohort (n=99)
Does frailty increase the risk of MACE and mortality in elderly patients with chronic coronary syndrome?
Effect estimate: RR 22.94 (95% CI 3.33-158.19)
Absolute Event Rate: 69.4% vs 20%
p-value: p=0.001
Frailty is a strong prognostic marker for increased mid-term MACE and mortality in elderly patients with chronic coronary syndrome.
May inform risk stratification in elderly chronic coronary syndrome; leaves open whether frailty modification alters outcomes.
INTRODUCTION: Frailty is a condition of elderly characterized by increased vulnerability to stressful events. Frail patients are more likely to have adverse events. The purposes of this study were to define frailty in patients aged ≥ 70 years with chronic coronary syndrome (CCS) and to evaluate mortality and prognostic significance of frailty in these patients. METHODS: We included 99 patients, ≥ 70 years old (mean age 74±5.3 years), with diagnosis of CCS. They were followed-up for up to 12 months. The frailty score was evaluated according to the Canadian Study of Health and Aging (CSHA). All patients were divided as frail or non-frail. The groups were compared for their characteristics and clinical outcomes. RESULTS: Fifty patients were classified as frail, and 49 patients as non-frail. The 12-month Major Adverse Cardiac Events (MACE) rate was 69.4% in frail patients and 20% in non-frail patients. Frailty increases the risk for MACE as much as 3.48 times. Two patients died in the non-frail group and 11 patients died in the frail group. Frailty increases the risk for death as much as 6.05 times. When we compared the aforementioned risk factors by multivariate analysis, higher CSHA frailty score was associated with increased MACE and death (relative risk [RR] = 22.94, 95% confidence interval [CI] 3.33-158.19, P=0.001, for MACE; RR = 7.41, 95% CI 1.44-38.03, P=0.016, for death). CONCLUSION: Being a frail elderly CCS patient is associated with worse outcomes. Therefore, frailty score should be evaluated for elderly CCS patients as a prognostic marker.
No takes yet. Share an insight, caveat, or question.
Özmen et al. (2020) conducted a cohort in chronic coronary syndrome (n=99). Frailty vs. Non-frail was evaluated on Major Adverse Cardiac Events (MACE) (RR 22.94, 95% CI 3.33-158.19, p=0.001). Frailty in elderly patients with chronic coronary syndrome significantly increased the risk of 12-month MACE compared to non-frail patients (69.4% vs 20%; RR 22.94, 95% CI 3.33-158.19, P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: